Skip to main content
Download PDF

Exposure to environmental factors increases connectivity between symptom domains in the psychopathology network

BMC Psychiatry volume 16, Article number: 223 (2016) Cite this article

Abstract

Background

We investigated to what degree environmental exposure (childhood trauma, urbanicity, cannabis use, and discrimination) impacts symptom connectivity using both continuous and categorical measures of psychopathology.

Methods

Outcomes were continuous symptom dimensions of self-reported psychopathology using the Self-report Symptom Checklist-90-R in 3021 participants from The Early Developmental Stages of the Psychopathology (EDSP) study and binary DSM-III-R categories of mental disorders and a binary measure of psychotic symptoms in 7076 participants from The Netherlands Mental Health Survey and Incidence Study (NEMESIS-1). For each symptom dimension in the EDSP and mental disorder in the NEMESIS-1 as the dependent variable, regression analyses were carried out including each of the remaining symptom dimensions/mental disorders and its interaction with cumulative environmental risk load (the sum score of environmental exposures) as independent variables.

Results

All symptom dimensions in the EDSP and related diagnostic categories in the NEMESIS-1 were strongly associated with each other, and environmental exposures increased the degree of symptom connectivity in the networks in both cohorts.

Conclusions

Our findings showing strong connectivity across symptom dimensions and related binary diagnostic constructs in two independent population cohorts provide further evidence for the conceptualization of psychopathology as a contextually sensitive network of mutually interacting symptoms.

Peer Review reports

Background

Psychopathology traditionally is represented as categories that implicitly refer to nosological entities (e.g. Major Depressive Disorder) or trans-diagnostic symptom dimensions based on symptom-level clustering (e.g. severity of depressive symptoms). Vinogradov and colleagues [1] proposed an associationist model of the symptom dimension of paranoia and suggested that the origins of psychopathology may lie in a network of mental states giving rise to acute phase transitions that Odgers and colleagues showed can be modelled as part of a dynamic system [2]. According to recent elaborations and extensions of this model, psychopathology can be conceptualized as a network of causally linked sets of symptoms, which reciprocally impact on each other over time to progress toward a more distinct syndrome forged through a specific pattern of a dynamic network for each syndrome [3–6].

The conceptualization of psychopathology as a dynamic network of symptoms may provide a particularly useful tool to understand pathways to mental illness. For example, transition of a false belief to a crystallized delusion can be modelled as a vicious cycle composed of interacting steps, in which an initial paranoid state, arising out of malformed hyperconnectivity among temporally contiguous perceptions, becomes fixated through perpetuation of an internally generated maladaptive schema to explain odd experiences [1]. Hyperconnectivity may also expand through the network across symptom domains, triggering a chain reaction, wherein the primary false belief (e.g. persecutory delusional ideation) may provoke anxiety under certain circumstances (e.g. being in public), which in turn leads to a misperception of external stimuli (illusions and hallucinations) that creates added confusion and anxiety which further impairs logical thought process, and solidifies delusionary explanation that finally becomes a fixed delusion.

Recent findings in large general population cohort studies suggest that exposure to environmental risk factors (childhood trauma, urbanicity, cannabis use, and discrimination) reinforces connectivity between symptoms of affective dysregulation and psychosis expression in a dose response fashion, in accordance with the theory of environment-induced disturbances spreading through the psychopathology network, increasing psychosis admixture, and progressively expanding and reinforcing connectivity that ultimately gives rise to transition to a more severe, distinct clinical syndrome requiring medical care [7–12].

If the environment impacts on the connection between psychosis and affective dysregulation, the question rises to what degree this is specific for these two domains of psychopathology. An alternative explanation is that the environment broadly impacts on the connectivity between domains of psychopathology. The emergence of psychosis may then be seen as an indicator of general severity of increasingly connected psychopathology, rather than a specific illness category [9, 13–15]. In the light of these findings, we hypothesize that the degree of exposure to environmental factors that are known to be associated with mental health would increase the extent of connectivity between symptom dimensions. Therefore, the aim was to investigate to what degree environmental exposure impacts on symptom connectivity analysing measures of psychopathology in two independent, general population datasets. In order to examine to what degree the findings would be stable across categorically and dimensionally defined psychopathology, connectivity was examined at the level of both continuous dimensions of self-reported psychopathology using the Self-report Symptom Checklist-90-R (SCL-90-R) and binary DSM-III-R categories of mental disorders and a binary measure of psychotic symptoms.

Methods

Samples

The Early Developmental Stages of the Psychopathology (EDSP) study

The EDSP study collected information on the prevalence, incidence, risk factors, comorbidity and course of mental symptoms and syndromes in a random representative population sample of 3021 adolescents and young adults living in the Munich area (aged 14–24 years at baseline) at 4 waves: at baseline (T0e), and at 3 follow-ups after on average 1.6 (T1e), 3.5 (T2e), and 8.4 years (T3e), respectively. Details were provided elsewhere [16–18].

The Netherlands Mental Health Survey and Incidence Study (NEMESIS-1)

The NEMESIS-1 study collected information on the prevalence, incidence, and course of mental disorders in a random representative general population sample of 7076 at 3 waves: at baseline (T0n), at the 12-month follow-up (T1n), and at the 36-month follow-up (T2n). Details were provided elsewhere [19].

The EDSP project has been approved by the Ethics Committee of the Faculty of the Technische Universitat Dresden (No. EK-13811). The NEMESIS-1 was conducted with the approval of the ethics committee of the Netherlands Institute of Mental Health and Addiction, Utrecht, the Netherlands. All respondents provided informed consent.

Instruments

Assessment of psychopathology

EDSP

At each time point, participants completed the SCL-90-R, a comprehensive self-report symptom inventory, multidimensional in nature, and oriented to screen for a broad range of psychological problems and psychopathology in community respondents and respondents with somatic and mental disorders. The SCL-90-R contains 90 items, scored on a 5-point severity scale, measuring 9 primary symptom dimensions named “somatization,” “obsessive-compulsive,” (OC) “interpersonal sensitivity,” “depression,” “anxiety,” “hostility”, “phobic anxiety,” “paranoid ideation,” and “psychoticism.” Reliability and validity of the SCL-90-R are quite satisfactory [20]. The time frame is the past 2 weeks.

Consistent with previous analyses in this sample, the paranoid ideation and psychoticism dimensions were combined to create a single “psychosis” dimension [9, 21, 22].

NEMESIS-1

The CIDI version 1.1 (computerized version) [23] was used to diagnose DSM III-R mental disorders. The CIDI is a structured interview developed by the World Health Organization and has been found to have high inter-rater reliability and high test–retest reliability for most common mental diagnoses [24]. The following diagnoses were included in the current analysis: manic episode, major depression, dysthymia and any anxiety disorder (panic disorder, agoraphobia, simple phobia, social phobia, generalized anxiety disorder, and obsessive–compulsive disorder). Diagnoses represent lifetime presence at baseline and interval presence at follow-up interviews.

In addition, a binary measure of any clinically relevant psychotic symptom [25] was used as a measure of psychosis [26]. Previous studies using the CIDI showed that the instrument a reliable and valid assessment of mental disorders, with the exception of psychotic disorders [27]. The CIDI psychosis section consists of 17 psychosis items concerning delusions (13 items) and hallucinations (4 items). Each item is scored on a 1–6 scale: ‶1,″ no symptom; ‶2,″ psychotic symptom present but not clinically relevant; ‶3,″ psychotic symptom result of drug use; ‶4,″ psychotic symptom result of somatic disease; ‶5,″ true psychotic symptom; and ‶6,″ possible plausible explanation for what appears to be a psychotic symptom. Each participant with a score of 2, 5, or 6 was followed up for validation. Individuals endorsing at least one lifetime psychotic symptom were interviewed using questions from the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID-I) over the telephone by an experienced clinician [28].

Assessment of Trauma

EDSP

Self-reported lifetime (baseline) and interval (follow-up) exposure to trauma was assessed using the N-section of the DIA-X/M-CIDI on trauma and PTSD comprising 9 groups of specific traumatic events (presented by a respondent list) such as “experienced physical threat,” “experienced serious accident,” or “being sexually abused as a child.” Visual presentation of the list allowed respondents and interviewers to avoid speaking about sometimes embarrassing and stigmatising trauma by simply indicating the number of the event. Consistent with earlier analyses [14, 29], positive responses to any of the events were coded as “self-reported trauma.”

NEMESIS-1

Subjects were asked, using a semi-structured interview, whether they had experienced any kind of emotional, physical, psychological or sexual abuse before age 16 years, providing examples for each type of trauma. Subjects answered ‘yes’ or ‘no’ to each of the questions and were asked to give an indication about the frequency on a six-point scale: 1, never; 2, once; 3, sometimes; 4, regular; 5, often; 6, very often. Consistent with previous work [30], in the analyses, experience of trauma was a priori dichotomized as follows: ‘no early trauma’ if the score on any item was ≤3, and ‘early trauma’ if the score on any item was >3.

Assessment of cannabis use

EDSP

Cannabis use was assessed with the L-section of the DIA-X/M-CIDI using the question “Have you ever used cannabis five times or more?” to define cannabis exposure. Conforming to previous work [22, 31], the DIA-X/M-CIDI cut-off of use of five times or more was used to define the binary variable for cannabis exposure.

NEMESIS-1

Consistent with previous work [32], the l-section of the CIDI 1.1 was used to define use of cannabis. In keeping with the previous work, “cannabis use,” was defined as use of cannabis a least once in the lifetime [32, 33].

Assessment of urbanicity

EDSP

In agreement with earlier work [14, 34], urbanicity was defined as living, at baseline, in the urban region of the German city of Munich versus the surrounding areas of Munich. The urban area, hence defined, had a population density of 4061 persons per square mile; for the rural area, this was 553 persons per square mile.

NEMESIS-1

Guided by previous work [28, 35], the original five-level classification of the urbanization measure expressed as density of addresses per km2 was dichotomized as follows: levels 1 (<500), 2 (500–900) and 3 (1000–1499) were coded as 0 and levels 4 (1500–2499) and 5 (≥2500) as 1.

Assessment of discrimination

NEMESIS-1

Perceived discrimination was assessed only in the NEMESIS-1 and not in EDSP. At baseline, participants were asked if they had experienced discrimination over the past year because of their skin colour or ethnicity; gender; age; appearance; disability; or sexual orientation [11]. Experienced discrimination was dichotomized as follows: ‘experienced discrimination’ if the participant answered one or more of the questions with “Yes”, and ‘no discrimination’ if the participant answered all questions with “No” [36].

Statistical analysis

All analyses were carried out with Stata 13.1 [37].

EDSP

Given the fact that outcome was measured at each time point, and in keeping with previous work [14, 38], data were analysed in the “long format” [each individual contributing 4 observations (T0e, T1e, T2e, and T3e)]. The analyses, therefore, were cross-sectional. Multilevel regression models using the XTREG command were applied to analyse whether the association between symptom dimensions increased as a function of the extent of exposure to environmental risk factors (continuous variable: from 0 = no exposure, to 3 = exposure to all environmental factors), hereafter referred to as ‘environmental exposure score’. Therefore, for each symptom dimension as the dependent variable, analyses were carried out including, in separate models, each of the 7 other symptom dimensions, and its interaction with environmental exposure score as independent variables. In order to correct for the clustering of multiple observations within subjects, all analyses were controlled by adding subject ID to the models as random intercepts.

NEMESIS-1

Given the fact that outcomes were similarly measured at each time point, data were analysed in the “long format” [each individual contributing 3 observations (T0n, T1n, T2n)]. To calculate the statistical interaction under an additive model (similar to the EDSP analyses described above), the BINREG procedure, which fits generalized linear models for the binomial family estimating risk differences, was used to model interactions between environmental exposure score (the categories of 3 and 4 exposures were merged due to small numbers in the latter to create a continuous variable: from 0 = no exposure, to 3 = exposure to ≥3 environmental factors) and diagnostic domains. Therefore, for each of the mental disorders as the dependent variable, analyses were carried out including each of the other 4 diagnostic domains and its interaction with environmental exposure score as independent variables. In order to correct for clustering of multiple observations within subjects, all analyses were controlled by adding subject ID to the models as random intercepts.

Results

Characteristics of the study populations at different time points are shown in Tables 1 and 2.

Table 1 Characteristics of the population at different time points (EDSP)
Full size table
Table 2 Characteristics of the population at different time points (NEMESIS-1)
Full size table

Symptom connectivity in the EDSP

All symptom dimensions were strongly connected to each other, and several significant interactions between symptom dimensions and environmental exposure score were found (Fig. 1a). With the exception of interpersonal sensitivity, for which reduced associations were apparent in the context of greater environmental exposure, connectivity between symptom dimensions increased with greater level of exposure to environmental risk factors (Table 3).

Fig. 1
figure 1

The impact of environmental exposure on connectivity across the symptom network. Fig. 1 (a) represents the EDSP sample. Fig. 1 (b) represents the NEMESIS-I sample. Arrows point out the direction of the association (from independent variable to dependent variable). Solid line indicates an increased association between symptom dimensions as a function of the degree of the environmental exposure. Dashed line indicates a reduced association between symptom dimensions as a function of the degree of the environmental exposure. Anx, Anxiety; Dep, Depression; Dys, Dysthmia; Hos, Hostility; IPS, Interpersonal Sensitivity; Man, Mania; OC, Obsessive-Compulsive; Pho, Phobic anxiety; Psy, Psychosis; Som, Somatization

Full size image
Table 3 The association between symptom dimensions as a function of exposure to environmental risk factors in the EDSP sample
Full size table

Environmental exposure increased associations of depression with other symptom dimensions except phobia. Similarly, significant interactions were found between the environmental exposure score and (i) interpersonal sensitivity, (ii) OC, and (iii) hostility in models predicting psychosis; and (i) hostility, and (ii) interpersonal sensitivity in models predicting OC. Regression analyses predicting anxiety revealed that associations with other symptom dimensions with the exception of somatization, increased as a function of the environmental exposure score.

Significant interactions were found between the environmental exposure score and (i) OC, and (ii) interpersonal sensitivity in models of somatization; and (i) OC, and (ii) interpersonal sensitivity in models of hostility. Regression analyses predicting phobia showed significant interactions between the environmental exposure score and each of the symptom dimensions. Regression analyses predicting sensitivity showed that associations between sensitivity and (i) anxiety, (ii) psychosis, and (iii) depression decreased as a function of the environmental exposure score.

Symptom connectivity in the NEMESIS-1

All diagnostic domains were strongly connected with each other, and significant interactions between domains and the environmental exposure score were found (Fig. 1b). Regression analyses predicting major depression showed that only the strength of the association between major depression and anxiety disorders increased as a function of environmental exposure, whereas environmental exposure increased the strength of associations between psychotic symptoms and each of the diagnostic domains (Table 4). Regression analyses predicting anxiety disorders showed only the association between anxiety disorders and psychotic symptoms increased as a function of environmental exposure. Significant interactions were found between the environmental exposure score and (i) major depression, (ii) psychotic symptoms, and (iii) anxiety disorders in models predicting mania; as well as (i) major depression and (ii) anxiety disorders in models of dysthymia (Table 3).

Table 4 The association between symptom dimensions as a function of exposure to environmental risk factors in the NEMESIS-1 sample
Full size table

Discussion

This study investigated to what degree connectivity between symptom dimensions and diagnostic categories is conditional on environmental exposures known to be associated with mental ill health, particularly psychosis. The principal findings were: (i) symptom dimensions and related diagnostic categories were strongly associated with each other; (ii) environmental exposures increased the level of connectivity.

Psychopathology as a network of symptoms

Our findings showing strong connectivity across symptom dimensions and related binary diagnostic constructs in two independent population cohorts confirm previous results [9], and provide additional evidence for the conceptualization of psychopathology as a network of mutually interacting symptoms [3–6]. Several studies in general population cohorts have shown that symptom domains do not vary in isolation but are interconnected, even before the emergence of a distinct clinical state, and that interactions between symptoms, including transdiagnostic ‘contiguous symptoms’ (e.g. hallucinations x delusions) and ‘disjointed symptoms’ (e.g. affective dysregulation x paranoia) predict transition to a more severe mental state [39–41]. Micro-level research of psychopathology at the level of momentary experiences in the flow of daily life using the Experience Sampling Method (ESM) has demonstrated that there is a continuous dynamic interplay between momentary mental states, with increasing connectivity between momentary states (paranoia, positive, and negative affect) predicting increased severity [42] and onset of need for care [43]. Similarly, an investigation of the underlying dynamic network structure of psychopathology revealed that mental states of individuals with psychosis or depression were more connected than those of healthy controls, with more feedback loops across negative momentary mental states (e.g. “insecure”, “suspicious”) [44]. There is some evidence that an alteration in the pattern of mood dynamics, marked by increased connectivity across the network, may give rise to an unstable condition, or tipping point, where even a subthreshold stimulus may provoke an abrupt transition to clinical depression [45].

The impact of environmental exposures on the psychopathology network

The findings indicating increased symptom connectivity as a function of the level of environmental exposure score lend further support to previous findings showing that exposure to environmental risk factors (trauma, urbanicity, cannabis) additively increase psychosis expression in affective spectrum disorder in a dose–response fashion [9]. Smeets and colleagues demonstrated, both in general population samples [46] and in those at high genetic risk (siblings and parents of patients) [8] that rates of co-occurrence of hallucinations and delusions are moderated by environmental exposure (cannabis use and childhood trauma). Another recent study in the general population showed that when symptoms were grouped together to form a connected symptom domain, association with childhood trauma became significantly stronger than when symptoms were analysed in isolation [7]. Similarly, an ESM study showed that childhood adversity moderated the impact of negative affect on paranoia levels [47]. Furthermore, meta-analytic work has shown that environmental exposures increase the way psychotic symptoms impact on to themselves over time – i.e. the rate of persistence or the rate of transfer over time. Thus‚ greater level of exposure to childhood trauma predicts increased persistence of psychotic experiences [48].

Strengths and limitations

The major strength of this study is the analysis of hypothesized psychopathology networks at levels of both continuous symptom dimensions and related binary diagnostic constructs in two independent large, representative population cohorts assessed with standardized clinical instruments administered by trained interviewers, thus increasing the generalizability of our findings. However, there are several limitations that should be taken into consideration. First, observations from all time points were combined in the ‘long format’–cross-sectional in nature. This is a practical solution at the current stage, given the lack of a sufficiently large dataset with intensive repeated assessments over an extended time frame, allowing for sequential analysis of the association between environmental exposures and symptom connections. While cross-sectional analysis increases reliability, it may not be the optimal approach to elucidate causal associations between environmental exposures and symptom connectivity over time. Future studies should therefore aim to investigate large cohorts with more frequent and fine-grained follow-ups in order to gain more insight into the dynamic formation of psychopathology networks under the influence of environmental exposures. Second, based on previous evidence indicating that environmental factors additively reinforce each other, possibly impacting on the same underlying mechanism, environmental risk factors were combined to construct a cumulative environmental risk load. The use of a score reflecting combined environmental impact increased statistical power and reduced type I error. On the other hand, while environmental factors may not all contribute equally to the cumulative environmental impact, similar weights were assigned to each environmental factor, which may have produced a degree of imprecision to the results.

Conclusions

Evidence indicates that environmental risk factors impact on connections between symptoms in a causal network, increasing connectivity, thus adding to tipping the balance towards transition from the initial set of subthreshold symptoms to a more severe mental state and a more distinct clinical syndrome requiring treatment.

Under the framework of connected symptoms in a network, future research may focus on the divergent and interactive impacts of vulnerability factors (environmental and genetic) on pattern formation across symptoms and mental states, and investigate whether there are specific patterns in the network that may be useful to differentiate and predict psychopathology at disorder and symptom levels. Despite high cost, the optimal research design would require a large enough cohort with a longitudinal design to assess psychopathology (both at micro and macro levels) and environmental exposures over a longer period of time, spanning the period of transition from a normal to a clinical state e.g. in late adolescence and early adulthood. A more practical approach to understanding changes of network patterns leading to progression to a clinical syndrome may be to use a sibling-case–control design providing the opportunity to investigate the symptom network at different levels of genetic and non-genetic susceptibility [49].

Abbreviations

EDSP study, The Early Developmental Stages of the Psychopathology; ESM, the Experience Sampling Method; NEMESIS-1, The Netherlands Mental Health Survey and Incidence Study; OC, obsessive-compulsive; SCID-I, the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; SCL-90-R, the Self-report Symptom Checklist-90-R

References

  1. Vinogradov S, King RJ, Huberman BA. An associationist model of the paranoid process: application of phase transitions in spreading activation networks. Psychiatry. 1992;55(1):79–94.

    CAS  PubMed  Google Scholar 

  2. Odgers CL, Mulvey EP, Skeem JL, Gardner W, Lidz CW, Schubert C. Capturing the ebb and flow of psychiatric symptoms with dynamical systems models. Am J Psychiatry. 2009;166(5):575–82.

    Article  PubMed  Google Scholar 

  3. Borsboom D, Cramer AOJ. Network analysis: an integrative approach to the structure of psychopathology. Annu Rev Clin Psychol. 2013;9:91–121.

    Article  PubMed  Google Scholar 

  4. Bystritsky A, Nierenberg AA, Feusner JD, Rabinovich M. Computational non-linear dynamical psychiatry: a new methodological paradigm for diagnosis and course of illness. J Psychiatr Res. 2012;46(4):428–35.

    Article  CAS  PubMed  Google Scholar 

  5. Van Os J. The dynamics of subthreshold psychopathology: implications for diagnosis and treatment. Am J Psychiatry. 2013;170(7):695–8.

    Article  PubMed  Google Scholar 

  6. Goekoop R, Goekoop JG. A network view on psychiatric disorders: network clusters of symptoms as elementary syndromes of psychopathology. PLoS ONE. 2014;9(11), e112734.

    Article  PubMed  PubMed Central  Google Scholar 

  7. van Nierop M, Viechtbauer W, Gunther N, Van Zelst C, De Graaf R, Ten Have M, Van Dorsselaer S, Bak M, Genetic R, investigators OUoP, et al. Childhood trauma is associated with a specific admixture of affective, anxiety, and psychosis symptoms cutting across traditional diagnostic boundaries. Psychol Med. 2014;45:1–12.

    Google Scholar 

  8. Smeets F, Lataster T, Viechtbauer W, Delespaul P. Evidence That Environmental and Genetic Risks for Psychotic Disorder May Operate by Impacting on Connections Between Core Symptoms of Perceptual Alteration and Delusional Ideation. Schizophr Bull. 2014;41:sbu122.

    Google Scholar 

  9. Guloksuz S, Van Nierop M, Lieb R, Van Winkel R, Wittchen HU, Van Os J. Evidence that the presence of psychosis in non-psychotic disorder is environment-dependent and mediated by severity of non-psychotic psychopathology. Psychol Med. 2015;1–13.

  10. Fusar-Poli P, Nelson B, Valmaggia L, Yung AR, McGuire PK. Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr Bull. 2014;40(1):120–31.

    Article  PubMed  Google Scholar 

  11. Janssen I, Hanssen M, Bak M, Bijl RV, De Graaf R, Vollebergh W, McKenzie K, Van Os J. Discrimination and delusional ideation. Br J Psychiatry. 2003;182:71–6.

    Article  CAS  PubMed  Google Scholar 

  12. Morgan C, Charalambides M, Hutchinson G, Murray RM. Migration, ethnicity, and psychosis: toward a sociodevelopmental model. Schizophr Bull. 2010;36(4):655–64.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kelleher I, Keeley H, Corcoran P, Lynch F, Fitzpatrick C, Devlin N, Molloy C, Roddy S, Clarke MC, Harley M, et al. Clinicopathological significance of psychotic experiences in non-psychotic young people: evidence from four population-based studies. Br J Psychiatry. 2012;201:26–32.

    Article  PubMed  Google Scholar 

  14. Wigman JT, Van Nierop M, Vollebergh WA, Lieb R, Beesdo-Baum K, Wittchen HU, Van Os J. Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity--implications for diagnosis and ultra-high risk research. Schizophr Bull. 2012;38(2):247–57.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Wigman JT, Van Os J, Abidi L, Huibers MJ, Roelofs J, Arntz A, Kelleher I, Peeters FP. Subclinical psychotic experiences and bipolar spectrum features in depression: association with outcome of psychotherapy. Psychol Med. 2014;44(2):325–36.

    Article  CAS  PubMed  Google Scholar 

  16. Wittchen HU, Lieb R, Pfister H, Schuster P. The waxing and waning of mental disorders: evaluating the stability of syndromes of mental disorders in the population. Compr Psychiatry. 2000;41(2 Suppl 1):122–32.

    Article  CAS  PubMed  Google Scholar 

  17. Wittchen HU, Perkonigg A, Lachner G, Nelson CB. Early developmental stages of psychopathology study (EDSP): objectives and design. Eur Addict Res. 1998;4(1–2):18–27.

    Article  CAS  PubMed  Google Scholar 

  18. Zimmermann P, Bruckl T, Lieb R, Nocon A, Ising M, Beesdo K, Wittchen HU. The interplay of familial depression liability and adverse events in predicting the first onset of depression during a 10-year follow-up. Biol Psychiatry. 2008;63(4):406–14.

    Article  PubMed  Google Scholar 

  19. Bijl RV, Van Zessen G, Ravelli A, De Rijk C, Langendoen Y. The Netherlands Mental Health Survey and Incidence Study (NEMESIS): objectives and design. Soc Psychiatry Psychiatr Epidemiol. 1998;33(12):581–6.

    Article  CAS  PubMed  Google Scholar 

  20. Derogatis L, Cleary P. Confirmation of the dimensional structure of the SCL-90: a study in construct validation. J Clin Psychol. 1977;33:981–9.

    Article  Google Scholar 

  21. Cougnard A, Marcelis M, Myin-Germeys I, De Graaf R, Vollebergh W, Krabbendam L, Lieb R, Wittchen HU, Henquet C, Spauwen J, et al. Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness-persistence model. Psychol Med. 2007;37(4):513–27.

    Article  PubMed  Google Scholar 

  22. Henquet C, Krabbendam L, Spauwen J, Kaplan C, Lieb R, Wittchen HU, Van Os J. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ. 2005;330(7481):11.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Smeets R, Dingemans P. Composite international diagnostic interview (CIDI), Version 1.1. Amsterdam/Geneva: World Health Organization; 1993.

    Google Scholar 

  24. Wittchen H-U. Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res. 1994;28(1):57–84.

    Article  CAS  PubMed  Google Scholar 

  25. Van Os J, Hanssen M, Bijl R, Ravelli A. Straus (1969) revisited: A psychosis continuum in the general population? Schizophr Res. 2000;45(1–2):11–20.

    Article  CAS  PubMed  Google Scholar 

  26. Bijl RV, Ravelli A, Van Zessen G. Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol. 1998;33(12):587–95.

    Article  CAS  PubMed  Google Scholar 

  27. Andrews G, Peters L. The psychometric properties of the Composite International Diagnostic Interview. Soc Psychiatry Psychiatr Epidemiol. 1998;33(2):80–8.

    Article  CAS  PubMed  Google Scholar 

  28. Van Os J, Hanssen M, Bijl RV, Vollebergh W. Prevalence of psychotic disorder and community level of psychotic symptoms: an urban–rural comparison. Arch Gen Psychiatry. 2001;58(7):663–8.

    Article  CAS  PubMed  Google Scholar 

  29. Spauwen J, Krabbendam L, Lieb R, Wittchen HU, Van Os J. Impact of psychological trauma on the development of psychotic symptoms: relationship with psychosis proneness. Br J Psychiatry. 2006;188:527–33.

    Article  PubMed  Google Scholar 

  30. Janssen I, Krabbendam L, Bak M, Hanssen M, Vollebergh W, Graaf Rd, Os J. Childhood abuse as a risk factor for psychotic experiences. Acta Psychiatr Scand. 2004;109(1):38–45.

    Article  CAS  PubMed  Google Scholar 

  31. Kuepper R, Van Os J, Lieb R, Wittchen HU, Hofler M, Henquet C. Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ. 2011;342:d738.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Van Os J, Bak M, Hanssen M, Bijl RV, De Graaf R, Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol. 2002;156(4):319–27.

    Article  CAS  PubMed  Google Scholar 

  33. Van Nierop M, Lataster T, Smeets F, Gunther N, Van Zelst C, De Graaf R, Ten Have M, Van Dorsselaer S, Bak M, Myin-Germeys I, et al. Psychopathological mechanisms linking childhood traumatic experiences to risk of psychotic symptoms: analysis of a large, representative population-based sample. Schizophr Bull. 2014;40 Suppl 2:S123–30.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Spauwen J, Krabbendam L, Lieb R, Wittchen HU, Van Os J. Does urbanicity shift the population expression of psychosis? J Psychiatr Res. 2004;38(6):613–8.

    Article  PubMed  Google Scholar 

  35. Van Os J, Hanssen M, Bak M, Bijl RV, Vollebergh W. Do urbanicity and familial liability coparticipate in causing psychosis? Am J Psychiatry. 2003;160(3):477–82.

    Article  PubMed  Google Scholar 

  36. Gevonden MJ, Selten JP, Myin-Germeys I, De Graaf R, Ten Have M, Van Dorsselaer S, Van Os J, Veling W. Sexual minority status and psychotic symptoms: findings from the Netherlands Mental Health Survey and Incidence Studies (NEMESIS). Psychol Med. 2014;44(2):421–33.

    Article  CAS  PubMed  Google Scholar 

  37. StataCorp. Stata/SE Statistical Software, Release 13.1. In: College Station, TX: StataCorp LP. 2013.

    Google Scholar 

  38. Dominguez MD, Wichers M, Lieb R, Wittchen HU, Van Os J. Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study. Schizophr Bull. 2011;37(1):84–93.

    Article  CAS  PubMed  Google Scholar 

  39. Freeman D, Startup H, Dunn G, Cernis E, Wingham G, Pugh K, Cordwell J, Kingdon D. The interaction of affective with psychotic processes: a test of the effects of worrying on working memory, jumping to conclusions, and anomalies of experience in patients with persecutory delusions. J Psychiatr Res. 2013;47(12):1837–42.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Freeman D, Dunn G, Fowler D, Bebbington P, Kuipers E, Emsley R, Jolley S, Garety P. Current paranoid thinking in patients with delusions: the presence of cognitive-affective biases. Schizophr Bull. 2013;39(6):1281–7.

    Article  PubMed  Google Scholar 

  41. Smeets F, Lataster T, Van Winkel R, De Graaf R, Ten Have M, Van Os J. Testing the hypothesis that psychotic illness begins when subthreshold hallucinations combine with delusional ideation. Acta Psychiatr Scand. 2013;127(1):34–47.

    Article  CAS  PubMed  Google Scholar 

  42. Wigman JT, Van Os J, Thiery E, Derom C, Collip D, Jacobs N, Wichers M. Psychiatric diagnosis revisited: towards a system of staging and profiling combining nomothetic and idiographic parameters of momentary mental states. PLoS ONE. 2013;8(3), e59559.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Van Os J, Lataster T, Delespaul P, Wichers M, Myin-Germeys I. Evidence that a psychopathology interactome has diagnostic value, predicting clinical needs: an experience sampling study. PLoS ONE. 2014;9(1), e86652.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Wigman JT, Van Os J, Borsboom D, Wardenaar KJ, Epskamp S, Klippel A, et al. Exploring the underlying structure of mental disorders: cross-diagnostic differences and similarities from a network perspective using both a top-down and a bottom-up approach. Psychol Med. 2015;1–13.

  45. van de Leemput IA, Wichers M, Cramer AOJ, Borsboom D, Tuerlinckx F, Kuppens P, Van Nes EH, Viechtbauer W, Giltay EJ, Aggen SH, et al. Critical slowing down as early warning for the onset and termination of depression. Proc Natl Acad Sci U S A. 2014;111(1):87–92.

    Article  CAS  PubMed  Google Scholar 

  46. Smeets F, Lataster T, Dominguez MD, Hommes J, Lieb R, Wittchen HU, Van Os J. Evidence that onset of psychosis in the population reflects early hallucinatory experiences that through environmental risks and affective dysregulation become complicated by delusions. Schizophr Bull. 2012;38(3):531–42.

    Article  PubMed  Google Scholar 

  47. Kramer I, Simons CJ, Wigman JT, Collip D, Jacobs N, Derom C, Thiery E, Van Os J, Myin-Germeys I, Wichers M. Time-lagged moment-to-moment interplay between negative affect and paranoia: new insights in the affective pathway to psychosis. Schizophr Bull. 2014;40(2):278–86.

    Article  PubMed  Google Scholar 

  48. Trotta A, Murray RM, Fisher HL. The impact of childhood adversity on the persistence of psychotic symptoms: a systematic review and meta-analysis. Psychol Med. 2015;45(12):2481–98.

    Article  CAS  PubMed  Google Scholar 

  49. European Network of National Networks studying Gene-Environment Interactions in S, Van Os J, Rutten BP, Myin-Germeys I, Delespaul P, Viechtbauer W, Van Zelst C, Bruggeman R, Reininghaus U, Morgan C, et al. Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull. 2014;40(4):729–36.

    Article  Google Scholar 

Download references

Acknowledgements

Principal investigators of the EDSP-Study are Dr. Hans-Ulrich Wittchen and Dr. Roselind Lieb. Core staff members of the EDSP group are: Dr. Kirsten von Sydow, Dr. Gabriele Lachner, Dr. Axel Perkonigg, Dr. Peter Schuster, Dipl.-Stat. Michael Höfler, Dipl.-Psych. Holger Sonntag, Dipl.-Psych. Tanja Brückl, Dipl.-Pych. Elzbieta Garczynski, Dr. Barbara Isensee, Dipl.-Psych. Agnes Nocon, Dr. Chris Nelson, Dipl.-Inf. Hildegard Pfister, Dr. Victoria Reed, Dipl.-Soz. Barbara Spiegel, Dipl.-Psych. Andrea Schreier, Dr. Ursula Wunderlich, Dr. Petra Zimmermann, Dipl.-Psych. Datja Beesdo and Dipl.-Psych. Antje Bitner. Scientific advisors are Dr. Jules Angst (Zurich), Dr. Jürgen Margraf (Basel), Dr. Günther Esser (Potsdam), Dr. Kathleen Merikangas (NIMH, Bethesda), Dr. Ron Kessler (Harvard, Boston) and Dr. Jim van Os (Maastricht).

Funding

This work is part of the Early Developmental Stages of Psychopathology (EDSP) Study and is funded by the German Federal Ministry of Education and Research (BMBF) project no. 01 EB9405/6, 01 EB9910/6, EB10106200, 01 EB0140, and 01 EB0440. Part of the fieldwork and analyses were also additionally supported by grants of the Deutsche Forschungsgemeinschaft (DFG) LA1148/1-1, WI2246/7-1, and WI709/8-1. NEMESIS is supported by The Netherlands Ministry of Health, Welfare and Sport (VWS), the Medical Sciences Department of The Netherlands Organization for Scientific Research (NWO), and the National Institute for Public Health and Environment (RIVM). The research leading to these results has received funding from the European Community’s Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI).

Availability of data and materials

All relevant data are reported within the paper. Data are available upon request.

Authors’ contributions

SG, MvN, MB, RdG, MtH, SvD, NG, RL, RvW, H-UW, and JvO contributed to the design of the study. SG and JvO wrote the first draft of this manuscript. SG and JvO carried out the statistical analyses of the study. MvN, MB, RdG, MtH, SvD, NG, RL, RvW, and H-UW contributed to interpretation of results and drafting of this manuscript. All authors read and approved the final manuscript.

Competing interests

All authors declare no competing interest.

Consent to publish

Not applicable.

Ethics and consent to participate

The EDSP project has been approved by the Ethics Committee of the Faculty of the Technische Universitat Dresden (No. EK-13811). The NEMESIS-1 was conducted with the approval of the ethics committee of the Netherlands Institute of Mental Health and Addiction, Utrecht, the Netherlands. All respondents provided informed consent.

Author information

Authors and Affiliations

  1. Department of Psychiatry and Psychology, Maastricht University Medical Centre, P.O. BOX 616, 6200 MD, Maastricht, The Netherlands

    Sinan Guloksuz, Martine van Nierop, Maarten Bak, Nicole Gunther, Ruud van Winkel & Jim van Os

  2. Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA

    Sinan Guloksuz

  3. Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands

    Ron de Graaf, Margreet ten Have & Saskia van Dorsselaer

  4. School of Psychology, Open University, Heerlen, The Netherlands

    Nicole Gunther

  5. Department of Psychology, Division of Clinical Psychology and Epidemiology, University of Basel, Basel, Switzerland

    Roselind Lieb

  6. University Psychiatric Center Katholieke Universiteit Leuven, campus Kortenberg, Leuvensesteenweg, Kortenberg, Belgium

    Ruud van Winkel

  7. Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany

    Hans-Ulrich Wittchen

  8. Max Planck Institute of Psychiatry, Munich, Germany

    Hans-Ulrich Wittchen

  9. King’s College London, King’s Health Partners, Department of Psychosis Studies, Institute of Psychiatry, London, UK

    Jim van Os

Authors
  1. Sinan Guloksuz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martine van Nierop
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maarten Bak
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ron de Graaf
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Margreet ten Have
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Saskia van Dorsselaer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Nicole Gunther
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Roselind Lieb
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ruud van Winkel
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Hans-Ulrich Wittchen
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jim van Os
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jim van Os.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guloksuz, S., van Nierop, M., Bak, M. et al. Exposure to environmental factors increases connectivity between symptom domains in the psychopathology network. BMC Psychiatry 16, 223 (2016). https://doi.org/10.1186/s12888-016-0935-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12888-016-0935-1

Keywords

BMC Psychiatry

ISSN: 1471-244X

Contact us